filmov
tv
Event: BTOG 2024
0:00:44
BTOG 2024: networking highlights and insights
0:03:18
Key insights from BTOG 2024: MARS 2 and HIT-MESO
0:03:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
0:02:53
BTOG Conference 2024 - Case Study
0:01:04
BTOG 2024 highlights: MARS 2 trial on mesothelioma surgery and TRACERx on lung cancer evolution
0:02:33
Reflecting on BTOG 2024: networking and multidisciplinary collaboration
0:04:20
Insights from BTOG 2024: advancements in TNM staging, systematic staging, & immunotherapy strategies
0:01:45
Exploring novel therapeutics in lung cancer: insights from BTOG 2024
0:00:54
Ongoing lung cancer trials and the potential of Trop2 biomarker at BTOG 2025
0:02:28
State of the Nation 2024 report: promising trends & challenges in lung cancer diagnosis & treatment
0:01:14
Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis
0:25:46
2024: Meet the Farm (and newbies), Ren's health problems, Tog Spot Good Stuff and more!
0:00:43
Advancements in stent technology for treating central airway obstruction
0:01:08
Personalized treatment planning for lung cancer with interstitial lung disease
0:00:49
Ongoing trials in thoracic radiotherapy: evaluating current role and significance
0:02:08
Managing lung cancer in ILD patients and implementing ctDNA testing in the NHS
0:02:10
Is there a role for radiotherapy in extensive-stage SCLC?
0:03:08
NI-HEART study results: cardiotoxicity after lung cancer radiotherapy
0:00:45
Assessing treatment options for lung cancer with interstitial lung disease
0:01:11
Addressing malignant central airway obstruction
0:01:33
Implementing liquid biopsies: advancing lung cancer care in the UK
0:00:37
STABLE-MATES: sublobar resection vs SAbR in high-risk patients with stage I NSCLC
0:01:44
Managing lung cancer patients with ILD: the oncology perspective
0:00:53
Assessing vaccine delivery in lung cancer care
Вперёд
welcome to shbcf.ru